LogicBio Therapeutics, Inc. Banner Image

LogicBio Therapeutics, Inc. has reached its limit for free report views

Work for LogicBio Therapeutics, Inc.? Upgrade Your Profile and unlock all your annual reports.

LogicBio Therapeutics, Inc.

  • Ticker LOGC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
LogicBio Therapeutics, Inc. Logo Image
  • 11-50 Employees
  • Based in Lexington, Massachusetts
LogicBio Therapeutics is dedicated to extending the reach of genetic medicine with pioneering targeted delivery platforms. LogicBio’s proprietary genome editing technology platform, GeneRide, enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. LogicBio is also developing aMore Next Generation Capsid platform for use in gene editing and gene therapies. LogicBio is developing these highly potent vectors for internal development candidates and potentially for business development collaborations. LogicBio is headquartered in Lexington, Mass.
LogicBio Therapeutics, Inc.

Most Recent Annual Report

LogicBio Therapeutics, Inc. MOST RECENT 2020 Annual Report

Report Locked. LogicBio Therapeutics, Inc. has reached its limit for free report views.

Older/Archived Annual Reports